About This Page
This is a clinician-written, evidence-based guide aligned to the MCC Examination Objectives. It is structured by clinical presentation — the way the MCCQE tests and the way patients actually present. Management reflects current Canadian guidelines (CMA, CFPC, CPS). Always cross-reference with institutional protocols and clinical judgment.
The Bottom Line
- A low platelet count is safety-critical — confirm it is real, assess bleeding severity, then separate decreased production, increased destruction/consumption, sequestration, pregnancy-related disease and drug-induced causes.
- Start with acuity and stability before narrowing the differential.
- Use CBC with differential, smear, coagulation studies and targeted tests according to the presentation pattern.
- Escalate urgently for abnormal smear, systemic red flags, major bleeding, sepsis, thrombosis, neurologic symptoms or suspected malignancy.
- Management is cause-directed and should follow Canadian transfusion, thrombosis and cancer diagnostic pathway principles.
Approach to the Presentation
Thrombocytopenia is approached as a clinical presentation rather than as a single diagnosis. Begin by assessing stability, bleeding or thrombosis risk, infection/sepsis features, medication exposures, pregnancy status where relevant, and systemic red flags. Then use the pattern of the abnormality — CBC lineage, smear morphology, coagulation pathway, node distribution, spleen size, or VTE pre-test probability — to select focused investigations. For MCCQE1, the safest answer is usually the one that identifies must-not-miss disease while avoiding reflex treatment of an isolated laboratory value.
Differential Diagnosis
| diagnosis | likelihood | key features | distinguishing test |
|---|---|---|---|
| Thrombotic thrombocytopenic purpura (TTP) | must-not-miss | Severe thrombocytopenia, microangiopathic haemolysis, neurologic symptoms, renal injury, fever; full pentad not required. | Schistocytes + haemolysis labs; ADAMTS13 confirms but plasma exchange should not wait. |
| Disseminated intravascular coagulation (DIC) | must-not-miss | Sepsis, trauma, obstetric complication, malignancy; bleeding and thrombosis, shock, organ dysfunction. | Low platelets, prolonged PT/aPTT, low fibrinogen, high D-dimer. |
| Heparin-induced thrombocytopenia (HIT) | must-not-miss | Platelet fall 5-10 days after heparin or sooner with prior exposure; thrombosis more common than bleeding. | 4Ts score, PF4/heparin immunoassay, functional assay confirmation. |
| Acute leukemia / marrow infiltration | must-not-miss | Thrombocytopenia with anaemia/neutropenia, blasts, fever, infection, bruising, bone pain, nodes, spleen. | CBC/smear and urgent bone marrow biopsy. |
| Immune thrombocytopenia (ITP) | common | Isolated thrombocytopenia, petechiae, bruising, epistaxis, otherwise well; post-viral or autoimmune. | Diagnosis of exclusion: isolated low platelets, normal smear except large platelets. |
| Drug-induced immune thrombocytopenia | common | Abrupt severe thrombocytopenia after quinine, TMP-SMX, beta-lactams, anticonvulsants, vancomycin or NSAIDs. | Temporal relationship and recovery after stopping drug; exclude TTP/DIC. |
| Liver disease / hypersplenism | common | Chronic mild-moderate thrombocytopenia, splenomegaly, alcohol use, viral hepatitis, cirrhosis signs. | Liver tests, INR, albumin, ultrasound showing portal hypertension/splenomegaly. |
| Gestational thrombocytopenia | common | Mild thrombocytopenia late pregnancy, asymptomatic, no hypertension/haemolysis, platelets usually >70. | Clinical diagnosis; normal BP/LFTs/haemolysis markers; postpartum resolution. |
| Preeclampsia / HELLP syndrome | less common | Pregnancy/postpartum, hypertension, RUQ pain, headache, visual symptoms, elevated liver enzymes, haemolysis, low platelets. | BP, urine protein, AST/ALT, LDH, bilirubin, smear; obstetric assessment. |
| Pseudothrombocytopenia | less common | Unexpected low platelet count without bleeding; platelet clumps on automated count. | Peripheral smear and repeat CBC in citrate tube. |
Red Flags & Key History
Symptoms
Headache, confusion, focal neurologic symptoms or seizure — TTP or intracranial bleeding concern
Fever, hypotension, rigors or severe infection symptoms — sepsis/DIC concern
Recent heparin exposure with new thrombosis — HIT until proven otherwise
Pregnancy/postpartum with headache, visual symptoms, RUQ pain or hypertension — preeclampsia/HELLP
Mucosal bleeding, wet purpura, heavy menstrual bleeding, melena or hematuria
Recent viral illness followed by isolated bruising — ITP pattern
Alcohol use, liver disease or known splenomegaly — hypersplenism pattern
Signs
Petechiae, purpura, oral blood blisters/wet purpura
Neurologic abnormality or altered mental status
Jaundice, pallor or dark urine suggesting haemolysis
Hepatosplenomegaly or lymphadenopathy
Hypertension or RUQ tenderness in pregnancy/postpartum
Approach to Investigation
First-line
Repeat CBC with differential and peripheral smearConfirm severity, exclude clumping, identify blasts, schistocytes, giant platelets, dysplasia and other cytopenias.
PT/INR, aPTT, fibrinogen, D-dimerAssess DIC and broader coagulopathy; ITP usually has normal coagulation studies.
Creatinine/eGFR, bilirubin, LDH, haptoglobin, reticulocytesScreen for microangiopathic haemolysis and renal involvement.
Medication and exposure reviewHeparin, quinine, antibiotics, anticonvulsants, chemotherapy, alcohol, herbals, infection/vaccination.
Second-line
HIV, hepatitis C and hepatitis B testingSecondary ITP and chronic liver disease causes; test based on risk and local practice.
4Ts score and PF4/heparin antibodyIf HIT suspected; stop heparin and use non-heparin anticoagulant in moderate/high probability.
Pregnancy-specific testsBP, urine protein, AST/ALT, LDH, bilirubin, creatinine, smear and fetal assessment when relevant.
Specialist
ADAMTS13 activityConfirms TTP but does not delay urgent treatment when suspicion is high.
Bone marrow biopsyIf pancytopenia, blasts, dysplasia, older adult atypical ITP or suspected malignancy.
Management Principles
Canadian Blood Services platelet transfusion guidance + Choosing Wisely Canada hematology recommendations1
Immediate triage
- Major bleeding, neurologic symptoms, schistocytes, DIC, HIT, pregnancy hypertensive disease or blasts require urgent escalation.
- Hold antiplatelet agents, NSAIDs, alcohol excess and suspected culprit drugs where safe.
- Avoid IM injections and unnecessary invasive procedures when platelets are very low.
2
Condition-specific treatment
- ITP: corticosteroids if treatment threshold met; IVIG for rapid rise or significant bleeding.
- TTP: urgent plasma exchange pathway plus immunosuppression; avoid prophylactic platelets unless life-threatening bleeding.
- HIT: stop all heparin, start non-heparin anticoagulation, avoid platelet transfusion unless severe bleeding.
- DIC: treat underlying cause and support with blood products only when bleeding/procedure requires it.
3
Platelet transfusion principles
- Use platelets for active serious bleeding, urgent procedures or profound hypoproliferative thrombocytopenia according to thresholds.
- Do not routinely transfuse platelets above standard prophylactic thresholds without bleeding.
- Consult transfusion medicine for refractoriness or alloimmunization concerns.
Complications & Pitfalls
- Always look at the smear: pseudothrombocytopenia, blasts and schistocytes change management.
- Platelets are not always the answer: prophylactic transfusion can be inappropriate in TTP/HIT.
- Do not call it ITP too early: ITP is isolated thrombocytopenia after excluding mimics.
- HIT causes clots: a platelet fall after heparin with thrombosis is a red flag.
- Pregnancy matters: distinguish gestational thrombocytopenia from HELLP, TTP and DIC.
MCCQE1 Exam Tips
- 1First step for an unexpected low platelet count: repeat CBC and smear.
- 2Isolated thrombocytopenia in a well patient = ITP/drug-induced pattern; cytopenias = marrow/systemic pattern.
- 3Schistocytes + thrombocytopenia + neurologic/renal findings = TTP; urgent plasma exchange.
- 4DIC has abnormal PT/aPTT/fibrinogen/D-dimer; ITP usually has normal coagulation studies.
- 5HIT timing is usually day 5-10 after heparin and presents with thrombosis.
- 6Low platelets plus hypertension/RUQ pain/elevated liver enzymes in pregnancy = HELLP.
practicetest your knowledge on thrombocytopeniaApply what you've learnt with MCCQE1-style questions from the iatroX Q-Bank — haematologic & oncologic and beyond.
open q-bank